NaturalPedia > Stock Prices

Quotes about Stock Prices from the world's top natural health / natural living authors

 Email this page to a friend   |  Click here for FREE email alerts

page 1 of 2 | Next ->

"Direct-to-consumer advertising has been a spectacular success, boosting sales and stock prices beyond the dreams of the early drug marketers. Every dollar the pharmaceutical industry spends on consumer ads generates $4.20 in increased sales. That's a better return on investment than that of the fast food industry, which spends about as much on advertising. Nearly one in three adults has talked about a specific drug to their doctor in response to a drug advertisement; one in eight walked out with a prescription for the drug they asked for." - Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (Get the book.)

"It's all about money and stock prices, not cures. The pharmaceutical industry responds by saying there are newer types of monoclonal antibodies under development or in clinical testing. But the simple fact remains, cancer patients are guinea pigs and the FDA approves ineffective therapies for cancer. In contrast to the failures of monoclonal antibody drugs, a recent report says "/'/ is well established that mushroom-extracted compounds are commonly used as immune boosters" ... and that "over 30 mushroom species have shown anticancer action in animals." - Bill Sardi, You Don't Have to be Afraid of Cancer Anymore (Get the book.)

"There is also no reason why a big jump shouldn't occur much more frequently than the bell curve lets us believe. stock prices, in this regard, resemble sales of books. Both are examples of informational cascades, where each actor imitates those who have chosen previously and, all together, act like a herd. Since it is based on very little information, herding behavior is inherently fragile and can stop abruptly and head in the opposite direction very swiftly on the basis of even a small amount of additional information." - William Bonner, Lila Rajiva, Mobs, Messiahs, and Markets: Surviving the Public Spectacle in Finance and Politics (Agora Series) (Get the book.)

"The NIH's top scientists are among the highest paid employees in the government, and its studies can affect the commercial viability of new drugs and the stock prices of biomedical companies. Dr. H. Bryan Brewer Jr., a high-ranking scientist at the NIH, was considered "one of the nation's leading experts on cholesterol" and part of a team that wrote the cholesterol guidelines that encouraged more aggressive prescription of cholesterol-lowering drugs. As the Los Angeles Times reports: "What doctors were not told for years is this." - Anthony Colpo, The Great Cholesterol Con: Why Everything You've been Told About Cholesterol, Diet and Heart Disease is Wrong (Get the book.)

"Once stock prices got to bubble levels, I had to think of a reason for why they might stay there—that was where that productivity razzamatazz came from. People wanted an explanation and I gave it to them. Do you think I learned nothing in all that time I spent with Ayn Rand? That miserable, self-absorbed old tart! Reading her books was painful enough—but can you imagine those egocentric gabfests in those pitiful little apartments in lower Manhattan? I thought I would go mad. She was a minor cult figure, but what did it gain her?" - William Bonner, Lila Rajiva, Mobs, Messiahs, and Markets: Surviving the Public Spectacle in Finance and Politics (Agora Series) (Get the book.)

"The result? stock prices keep climbing, profits keep growing and CEOs get wealthier. You'd think this would be enough corruption for one industry, but Big Pharma is just getting started. Experiment shows medical doctors to be glorified drug dealers, easily manipulated by drug companies Researchers sent a group of people, who said they saw the drug Paxil in a TV advertisement, into doctors' offices." - Mike Adams, Natural Health Solutions (Get the book.)

"With mostly good news, stock prices of Genentech, Monsanto, Pioneer, DuPont, and other GMO manufacturers soared in the bull market for tech stocks from 1990 to 2001. Affected by the propaganda as well as affecting the propaganda, Wall Street wildly supported genetic engineering. The stockholders and stockbrokers saw genetic modification as a potential huge return on investment for a wide range of genetically altered products." - Will Allen, The War on Bugs (Get the book.)

"Within five weeks, stock prices were in a new bull market, one that would, once again, take them up past 2,500 and then push on to the 12,000 mark 12 years later. Those were happy times; the nation was at peace, more or less. The nation was prosperous. George Bush, the elder, was in the White House. (Note: This was the Bush whose biggest foreign policy blunder was throwing up on the prime minister of Japan.) Greenspan did not understand that inflation was moderating and lending rates were in a long-term downtrend." - William Bonner, Lila Rajiva, Mobs, Messiahs, and Markets: Surviving the Public Spectacle in Finance and Politics (Agora Series) (Get the book.)

"New drug approvals, widely announced to the public to buoy stock prices and encourage public demand, may not be justified by the results of studies. For ethical reasons, new drugs should be compared with existing ones. An existing drug may be found to prolong survival times by six months and a new drug by nine months, which will likely be broadcast as a dramatic breakthrough increasing survival by 33-50%, depending how you compare the numbers (three months is half of six months, or a 50% increase; three months is a third of nine months, or a 33% increase)." - Bill Sardi, You Don't Have to be Afraid of Cancer Anymore (Get the book.)

"That was when I made my celebrated remark about stock prices. I wondered if they did not reflect a kind of "irrational exuberance." Whether they did or did not, I do not know. But I came to realize two things: one, people, especially my bosses, actually wanted prices that were irrationally exuberant; and two, prices could become far more irrationally exuberant if we put our minds to it. I was 70 years old at the time. I had weaseled (why not be honest about it?) my way to the top post by knowing the right people and by not saying anything anyone could disagree with." - William Bonner, Lila Rajiva, Mobs, Messiahs, and Markets: Surviving the Public Spectacle in Finance and Politics (Agora Series) (Get the book.)

"For example, news sources heralded the combination of Avastin and Eloxatin. stock prices of the drug companies involved rose and analysts predicted billions of dollars in sales. But the patients were short changed. The overall improvement in survival went from 10.7 to 12.5 months using the combination of Avastin and Eloxatin rather than just Avastin. News reports claimed a 26% reduction in risk of death from colon cancer, but the translation into actual months of added life was often left out of the news reports or buried in lower paragraphs of the reports." - Bill Sardi, You Don't Have to be Afraid of Cancer Anymore (Get the book.)

"Three-quarters of all deals do not pay back their cost of capital, and stock prices have fallen. However, I think the real question is not whether they delivered, but rather: what would have happened to these companies if they hadn't made the deal?'13 Size matters All the main pharma players are big. But some are bigger than others. The number one company, Pfizer, was worth $283.8 billion in April 2004- Based in New York, the firm had sales worth more than $40 billion in 2003, a 40% increase on 2002." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.)

"If a lack of such ability ate into the company's production of a steady stream of blockbuster drugs, it could depress stock prices and create intense pressure by stockholders and board members. The issue was becoming an obstacle in the path of innovation and profits, at least as seen by top executives in all major pharmaceutical companies. As the industry bible, Pharmaceutical Executive, put it: "Nearly 80 percent of all clinical studies for new products fail to finish on time, and 20 percent of those are delayed six months or longer." - Greg Critser, Generation Rx: How Prescription Drugs are Altering American Lives, Minds, and Bodies (Get the book.)

"Direct-to-consumer advertising has been a spectacular success, boosting sales and stock prices beyond the dreams of the early drug marketers. Every dollar the pharmaceutical industry spends on consumer ads generates $4.20 in increased sales. That's a better return on investment than that of the fast food industry, which spends about as much on advertising. Nearly one in three adults has talked about a specific drug to their doctor in response to a drug advertisement; one in eight walked out with a prescription for the drug they asked for." - Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (Get the book.)

"Meanwhile pharmaceutical stock prices continue to climb, and CEO compensation is more ludicrous every year. Downward spiral of disease management In 2005 prescribed for high cholesterol STATIN DRUGS Drug blocks cholesterol production Prescribed new drugs with new side effects (repeat) Drug blocks vitamin D production 2007: diagnosed with fictitious Osteoporosis Which inhibits calcium absorption The true dangers of drugs How dangerous are drugs, really?" - Mike Adams, Natural Health Solutions (Get the book.)

"The increasing prices of cancer drugs appear to be engineered to elevate stock prices, not reward true breakthroughs. For example, the cancer drug Erbitux was heralded as a breakthrough and caused stock in ImClone System to rise dramatically, only to fall flat when the FDA rejected research studies on its effectiveness. (This is the drug that household television queen Martha Stewart sold off on an inside tip from Samuel D. Waksal, ImClone's chief executive." - Bill Sardi, You Don't Have to be Afraid of Cancer Anymore (Get the book.)

"Twelve months does not appear to be long enough to begin to see as strong a tendency for extreme price movements to reverse themselves. Quite possibly, the tendency for individual countries' stock market valuations to grow dramatically and then to be reversed will diminish in the future. With freer capital movements than were possible during the periods covered by the examples in the tables, and with more and more global investors seeking profit opportunities buying undervalued countries or shorting overvalued countries, markets may become more stable." - Brian Fagan, Floods, Famines, and Emperors: El Nino and the Fate of Civilizations (Get the book.)

"That's what fuels our economy, that's what drives stock prices. So, armed with that information, one can now make an informed decision when it comes to the forces trying to influence us. Knowing, for instance, that by the television industry's own estimates, food manufacturers spend $12 billion annually marketing sugary cereals, candy, soda pop, and a grocery aisle full of unhealthy processed foods to children, may provide the incentive to turn off Saturday morning cartoon shows and find a soul-enriching activity to enjoy instead." - David H. Rippe, Jared Rosen, The Flip: Turn Your World Around (Get the book.)

"If that company wants its stock prices to rise, it has to increase sales by a sizable percentage every ninety days. Companies must sell more, and then more, and even more. In this kind of investment economy, weight gain is just collateral damage. But obesity is not the only collateral result of pressures for corporate growth. Food marketing strategies have changed social patterns. It is now socially acceptable to eat more food, more often, in more places." - Marion Nestle, What to Eat (Get the book.)

"Does God intend stock prices to rise, we ask ourselves? Will God let this plane land safely, we wondered recently? Where the hell did God let us leave the car keys? But though we have given the matter a good-faith try, we have never mastered it. Surely, Woodrow must have supped with the gods. Perhaps he had God's ear or even his throat. For the man could look into the future as easily as we can look into an empty beer stein." - William Bonner, Addison Wiggin, Empire of Debt: The Rise of an Epic Financial Crisis (Get the book.) "He might also have looked on the boom and bubble in the United States as unrelated and mistaken the run-up in stock prices as a consequence of the New Era wonder age, the new productivity of information age technology, or the newfound wisdom of the guiding hands at the Federal Reserve. He may even have referred to the productivity miracle as the source of such a wonderful thing." - William Bonner, Addison Wiggin, Empire of Debt: The Rise of an Epic Financial Crisis (Get the book.) "He might have been describing the mind-set of the contemporary American investor, who sees no limit to stock prices and no risk anywhere. And so he was?0 years ahead of his time. Voting cannot really increase the masses' well-being. It brings no more hogs to market, builds no more gadgets, improves no meals, nor does it increase the efficiency of the internal combustion engine." - William Bonner, Addison Wiggin, Empire of Debt: The Rise of an Epic Financial Crisis (Get the book.) "In 1982, interest rates were high and stock prices were low. In 1982, there were a few people who wanted to buy stocks, and many who didn't. In 1982, America, Inc., looked like a has-been economy. Its currency was widely considered near-trash and its bonds were described as "certificates of guaranteed confiscation." You could buy nearly the entire Dow for just one ounce of gold. Now it takes 22 ounces. The trend of the time, in 1982, was down. Then, as now, smart people considered it eternal. BusinessWeek proclaimed that equities were not just in a cyclical downturn, not just sick, but dead." - William Bonner, Addison Wiggin, Empire of Debt: The Rise of an Epic Financial Crisis (Get the book.)

"By the time the S&P 500 reached bottom in March 2003 it had fallen by half in real inflation-corrected terms. This outcome led to a change in investor psychology. I remember having breakfast with a woman and her husband at the very end of 2000, when the market was down substantially from its peak, the tech stocks down more than 50%. She said she did the investing for the family, and in the 1990s she had been a genius. He agreed. Now, she confided, her self-esteem had collapsed. Her perception of the market was all an illusion, a dream, she said. Her husband did not disagree." - Brian Fagan, Floods, Famines, and Emperors: El Nino and the Fate of Civilizations (Get the book.) "As can be seen from Figure 1.2, between 1995 and 2000 the real stock market valuations of Brazil, France, China, and Germany roughly tripled, while that of the United Kingdom roughly doubled. The year 1999, the year before the peak, saw real stock price increases averaging, over these ten countries, 58%. All countries' prices went up sharply in 1999; in fact the smallest increase, occurring in the United Kingdom, was still an impressive +16%." - Brian Fagan, Floods, Famines, and Emperors: El Nino and the Fate of Civilizations (Get the book.) "We thus see quite a substantial, though imperfect, tendency for major five-year stock price movement to be reversed in another five years, for both up movements and down movements. When we look at one-year real price changes in Tables 7.1 and 7.2, we find that the tendency toward reversals is less pronounced, as we would expect from past literature on prices of individual stocks. We find that of the twenty-five winning countries shown in Table 7." - Brian Fagan, Floods, Famines, and Emperors: El Nino and the Fate of Civilizations (Get the book.)

"When the pharmaceutical companies get politicians to require drug use or have the government buy drugs from the pharmaceutical companies as exorbitant inflated prices, the pharmaceutical companies make billions of dollars in profits and their stock prices soar. What is the incentive for the politicians to do this? Well, I am now blowing the whistle on one of the greatest scandals in the history of American government. The members of Congress have passed a law which allows them to buy and sell stocks on, in effect, "insider information." Listen to this very carefully." - Kevin Trudeau, Natural Cures They Don't Want You to Know About (Get the book.) "They know that once this vote is passed, certain pharmaceutical companies' stock prices will skyrocket. They then buy the stock knowing that the information about this windfall profit will be made public very soon. The congressmen have information that you and I do not have access to. They are given the right to make profits when you and I are denied that right. This should be criminal! In any other venue people would go to jail, but in Congress it is standard operating procedure. It's one of the perks of being a congressman or senator in Washington." - Kevin Trudeau, Natural Cures They Don't Want You to Know About (Get the book.) "USA Today reports that biotech stock prices soar after good cancer drug news. This article points out the fact that publicly traded drug companies have only one goal: to increase profits, which means selling more drugs. The article never mentions if the drugs are effective at preventing or curing cancer, but only talks about how much money the companies will make by selling the drugs. • Hotels are increasingly using self-service check-in kiosks to reduce costs and increase profits." - Kevin Trudeau, Natural Cures They Don't Want You to Know About (Get the book.)

"As more people bought in, stock prices climbed still higher—a dangerous positive feedback loop. During the height of the mania, of course, many more stocks went up then went down. The middle class entered fearlessly into the realm of the "sure thing" reassured by the presence of the new and august Federal Reserve as a force that would stabilize the business cycle, and by such authorities as Harvard economics professor Irving Fisher, who declared the arrival of permanent prosperity a few weeks before the stock market crash of October 1929." - James Howard Kunstler, The Long Emergency: Surviving the End of Oil, Climate Change, and Other Converging Catastrophes of the Twenty-First Century (Get the book.)

page 1 of 2 | Next ->

FAIR USE NOTICE: The research quoted here is provided under the protection of Fair Use provisions and published by the 501(c)3 non-profit Consumer Wellness Center for the purposes of public comment and education. Authors / publishers may submit books for consideration of inclusion here.

TERMS OF USE: Read full terms of use. Citations of text from NaturalPedia must include: 1) Full credit to the original author and book title. 2) Secondary credit to the Natural News Naturalpedia as a research resource and a link to www.NaturalPedia.com

This unique compilation of research is copyright (c) 2008, 2009 by the non-profit Consumer Wellness Center.

ABOUT THE CREATOR OF NATURALPEDIA: Mike Adams, the creator of NaturalPedia, is the editor of NaturalNews.com, the internet's top natural health news site, creator of the Honest Food Guide (www.HonestFoodGuide.org), a free downloadable consumer food guide based on natural health principles, author of Grocery Warning, The 7 Laws of Nutrition, Natural Health Solutions, and many other books available at www.TruthPublishing.com, creator of the earth-friendly EcoLEDs company (www.EcoLEDs.com) that manufactures energy-efficient LED lighting products, founder of Arial Software (www.ArialSoftware.com), a permission e-mail technology company, creator of the CounterThink Cartoon series (www.NaturalNews.com/index-cartoons.html) and author of over 1,500 articles, interviews, special reports and reference guides available at www.NaturalNews.com. Adams' personal philosophy and health statistics are available at www.HealthRanger.org.